Blood platelet score detects previously unmeasured risk of heart attack and stroke
Medical Xpress - Cardiology
AUGUST 20, 2024
Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels.
Medical Xpress - Cardiology
AUGUST 20, 2024
Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels.
DAIC
APRIL 6, 2024
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
DAIC
APRIL 6, 2024
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at ACC.24, 24, the American College of Cardiology Annual Annual Scientific Session.
Dr. Sanjay Gupta
DECEMBER 19, 2022
On the basis of these findings we told her that she had suffered a heart attack. She asked me why I felt she had had a heart attack and I explained to her that she had had chest pains and the blood test indicating damage to the heart was elevated and that was all we needed to say that she had had a heart attack.
All About Cardiovascular System and Disorders
APRIL 21, 2024
Stroke is often due to sudden loss of blood supply to a region of the brain which usually results in paralysis of a part of the body. Stroke could also be due to bleeding into a part of the brain. Strokes and heart disease are linked together in various ways. Stroke can occur after a heart attack as well.
DAIC
NOVEMBER 18, 2024
4] "Many patients taking antiplatelet therapy are simply not prescribed anticoagulants because of the fear of bleeding, leaving them without protection from the risk of stroke,” said Dan Bloomfield, MD, chief medical officer of Anthos Therapeutics. incidence rate for rivaroxaban to a 3.5% incidence rate for abelacimab 150 mg). [1] vs 4.6%).
Science Daily - Heart Disease
AUGUST 28, 2023
New research details the first oral drug for the treatment of a type of high cholesterol -- called Lp(a) -- that is a potentially more dangerous version of the so called 'bad' cholesterol, LDL, because it is stickier and may be more likely to cause blockages and blood clots in your arteries.
Let's personalize your content